Yüklüyor......
Metabolomics of Type 1 and Type 2 Diabetes
Type 1 and type 2 diabetes mellitus (DM) are chronic diseases that affect nearly 425 million people worldwide, leading to poor health outcomes and high health care costs. High-throughput metabolomics screening can provide vital insight into the pathophysiological pathways of DM and help in managing...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6566263/ https://ncbi.nlm.nih.gov/pubmed/31109071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20102467 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|